Arginine nutrition and cardiovascular function

Journal of Nutrition

Volumn 130, Issue 11, 2000, Pages 2626-2629

  Wu, Guoyao ^a,b   Meininger, Cynthia J ^b  

^a TEXAS A AND M UNIVERSITY   (United States)

^b TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

Author keywords

Arginine; Cardiovascular disease

Indexed keywords

ARGININE; ENDOTHELIN 1; INSULIN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ARTICLE; CARDIOVASCULAR DISEASE; CIGARETTE SMOKING; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DIET SUPPLEMENTATION; ENDOTHELIUM CELL; HEART FAILURE; HUMAN; HUMAN CELL; HYPERCHOLESTEROLEMIA; HYPERTENSION; INSULIN RESISTANCE; OBESITY; PERIPHERAL VASCULAR DISEASE; RISK FACTOR;

EID: 0033744268     PISSN: 00223166     EISSN: None     Source Type: Journal    
DOI: 10.1093/jn/130.11.2626     Document Type: Article

References (40)

1. Arginine metabolism: Nitric oxide and beyond
2. Arginine needs, physiological state and usual diets. A reevaluation
3. Nitric oxide as a signaling molecule in the vascular system: An overview
4. Cardiovascular effects of L-arginine
5. Cellular and molecular mechanisms of endothelial cell dysfunction
6. Dietary protein or arginine deficiency impairs constitutive and inducible nitric oxide synthesis by young rats
7. Impaired wound healing and angiogenesis in eNOS-deficient mice
8. Nitric oxide as a bifunctional regulator of apoptosis
9. Vascular effects of L-arginine: Anything beyond a substrate for the NO-synthase?
10. Pharmacological concentrations of arginine influence human whole blood viscosity independent of nitric oxide synthase activity in vitro
11. Intravenous administration of L-arginine inhibits angiotensin-converting enzyme in humans
12. Effect of L-arginine on in vitro plasmin generation and fibrinogenolysis
13. L-Arginine supplementation in hypercholesterolemic rabbits normalizes leukocyte adhesion to non-endothelial matrix
14. Novel mechanism for endothelial dysfunction - Dysregulation of dimethylarginine dimethylaminohydrolase
15. L-Arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans
16. Oral L-arginine improves endothelium-dependent dilation in hypercholesterolemic young adults
17. Endothelial dysfunction in hypercholesterolemia is reversed by a nutritional product designed to enhance nitric oxide activity
18. Effects of L-arginine on atherogenesis and endothelial dysfunction due to secondhand smoke
19. L-Arginine normalizes coronary vasomotion in long-term smokers
20. Effect of L-arginine infusion on infants with persistent pulmonary hypertension of the newborn
21. L-Arginine and substance P reverse the pulmonary endothelial dysfunction caused by congenital heart surgery
22. Effect of L-arginine infusion on systemic and renal hemodynamics in hypertensive patients
23. Review of alteration in endothelial nitric oxide production in diabetes
24. Reversal effects of L-arginine treatment on blood pressure and vascular responsiveness of streptozotocin-diabetic rats
25. Hemodynamic effects of acute hyperglycemia in type 2 diabetic patients
26. Mice with gene disruption of both endothelial and neuronal nitric oxide synthase exhibit insulin resistance
27. Effects of low-dose L-arginine on insulin-mediated vasodilatation and insulin sensitivity
28. Aging-associated endothelial dysfunction in humans is reversed by L-arginine
29. Prolonged L-arginine on cardiovascular mass and myocardial hemodynamics and collagen in aged spontaneously hypertensive rats and normal rats
30. Oral L-arginine improves endothelium-dependent dilatation and reduces monocyte adhesion to endothelial cells in young men with coronary artery disease
31. Long-term L-arginine supplementation improves small-vessel coronary endothelial function in humans
32. Biochemical evidence for impaired nitric oxide synthesis in patients with peripheral arterial occlusive disease
33. Nutritional therapy for peripheral arterial disease: A double-blind, placebo-controlled, randomized trial of HeartBar
34. Nitric oxide deficiency contributes to large cerebral infarct size
35. L-Arginine limits myocardial cell death secondary to hypoxia-reoxygenation by a cGMP-dependent mechanism
36. Randomized, double-blind, placebo-controlled study of supplemental oral L-arginine in patients with heart failure
37. Correction of endothelial dysfunction in chronic heart failure: Additional effects of exercise training and oral L-arginine supplementation
38. Effects of oral administration of L-arginine on renal function in patients with heart failure
39. L-Arginine reduces heart rate and improves hemodynamics in severe congestive heart failure
40. Oral L-arginine in patients with coronary artery disease on medical management